Skip to main content
Skip to section navigation
Skip to footer
News
Careers
Contact us
Medical Information
About Us
Overview
Management Team
Board of Directors
Compliance and Transparency
Pipeline & Portfolio
Pipeline
Our Therapies
Science
Overview
Publications
Clinical Trials
Investors
Overview
News
Events & Presentations
Stock Info
Financials & Filings
Governance
IR Resources
News
Careers
Contact us
Medical Information
SEC Filings
Investors
Investors
Overview
News
Press Releases
Email Alerts
Events & Presentations
Events
Presentations
Stock Info
Quote and Chart
Historical Performance
Analyst Coverage
Financials & Filings
Financial Results
SEC Filings
Annual Reports
Email Alerts
Governance
Overview
Governance Documents
Management Team
Board of Directors
Board Committees
IR Resources
Investor FAQs
Email Alerts
Contacts
Filing Type:
View All
10-K
10-Q
144
20-F
3
4
424B4
424B5
424B7
6-K
6-K/A
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DRS
DRS/A
EFFECT
F-1
F-1/A
F-1MEF
F-3ASR
F-6
F-6/A
PRE 14A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2016
Date
Form
Description
PDF
XBRL
Pages
12/02/22
6-K
Form 6-K: Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
12/02/22 6-K Documents
expand_more
EX-99.1
9
11/18/22
6-K/A
Form 6-K/A: Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
11/18/22 6-K/A Documents
expand_more
EX-99.1
18
11/14/22
6-K
Form 6-K: Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
11/14/22 6-K Documents
expand_more
EX-99.1
7
11/09/22
6-K
Form 6-K: Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
11/09/22 6-K Documents
expand_more
EX-99.1
EX-99.2
EX-99.3
EX-99.4
169
09/30/22
6-K
Form 6-K: Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
09/30/22 6-K Documents
expand_more
EX-5.1
EX-5.2
24
09/30/22
424B7
Form 424B7: Prospectus filed pursuant to Rule 424(b)(7)
09/30/22 424B7 Documents
expand_more
EX-FILING FEES
86
09/09/22
6-K
Form 6-K: Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
09/09/22 6-K Documents
expand_more
EX-1.1
EX-5.1
EX-99.1
60
09/09/22
424B5
Form 424B5: Prospectus filed pursuant to Rule 424(b)(5)
09/09/22 424B5 Documents
expand_more
EX-FILING FEES
95
09/09/22
6-K
Form 6-K: Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
09/09/22 6-K Documents
expand_more
EX-99.1
EX-99.2
39
09/07/22
SC 13G/A
Form SC 13G/A: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
3
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
7
Page
8
Page
9
Page
10
Page
11
Page
12
Page
13
Page
14
Page
15
Page
16
…
Page
19
Next Page
arrow_forward
Select a page:
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
email
Email Alerts
contact_page
Contacts
rss_feed
RSS News Feed
account_tree
Sitemap